A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
Clinical trial NCT07778498 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07778498
- Sponsor
- Phrontline Biopharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2029-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.